GSK Investigational Site

Venray 5801 CE

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis — Completed